Algeria has begun its national COVID-19 vaccination campaign, the Ministry of Health announced recently. The rollout follows the arrival of an initial batch of doses procured through the COVAX facility, according to France 24. Priority groups, including frontline healthcare workers and the elderly, are expected to receive the first injections, paving the way for broader economic recovery efforts.
The campaign marks a turning point for Algeria’s public health response and signals a gradual easing of restrictions that have weighed on small businesses and informal traders. Recent data from Algerian customs show that non-oil imports fell 12% in 2020, affecting retail and manufacturing supply chains. Entrepreneurs in sectors like tourism and hospitality — already hard hit since March 2020 — may see incremental relief as public confidence improves.
Health authorities have designated vaccination centers across the country, including major hospitals in Algiers, Oran, and Constantine. Logistics teams are coordinating cold-chain storage and distribution, though cold-chain capacity remains limited outside urban areas. Entrepreneurs in logistics and cold storage are likely to benefit from growing demand for temperature-controlled transport and storage solutions.
The government has secured 10 million doses from COVAX, with additional supplies expected from bilateral agreements. Earlier reports indicate Algeria has also engaged with manufacturers in Russia, China, and India to ensure diverse sourcing. This multi-pronged approach may help stabilize vaccine availability and reduce dependency on a single supplier, a concern raised by local business associations during recent economic forums.
Public health experts note that rapid vaccination will be critical to reopening borders and restoring air travel, which accounts for a significant share of Algeria’s tourism revenue. Last year, the sector saw a 75% drop in international arrivals, according to the National Office of Statistics. Entrepreneurs in travel services, hotels, and tour operations have been operating at reduced capacity, relying on domestic demand.
The vaccination launch comes amid rising infections in neighboring countries, increasing pressure on Algeria’s healthcare system. Recent reports from the World Health Organization highlight concerns about new variants and their potential impact on Algeria’s fragile recovery. Entrepreneurs should prepare for potential disruptions as health protocols evolve.
Small and medium-sized enterprises (SMEs) that pivoted to digital platforms during lockdowns may continue to benefit from sustained consumer behavior changes. Online retail sales increased by 40% in 2020, according to the Algerian Chamber of Commerce. Entrepreneurs who invested in e-commerce infrastructure and digital payment systems are likely to see continued growth as public mobility gradually improves.
The government has not yet detailed plans for mandatory vaccination in workplaces, but businesses in sectors with high public exposure are expected to encourage immunization among staff. Entrepreneurs should monitor official guidance to align workplace policies with public health recommendations.
Access to vaccines remains a concern in rural areas, where infrastructure and awareness campaigns may lag. Local NGOs and community organizations are expected to play a role in outreach. Entrepreneurs with operations outside major cities can contribute by supporting employee transportation to vaccination centers or providing paid leave for staff to receive doses.
Key takeaway for entrepreneurs
Algeria’s vaccine rollout may ease mobility restrictions and help restart tourism and retail sectors hit by the pandemic. SMEs with digital infrastructure and flexible supply chains are best positioned to capitalize on gradual recovery. Businesses should track vaccine deployment and health guidance to adapt operations and workforce policies accordingly.
💡 Starting a business in Algeria? GlobalStart guides you step by step: procedures, real costs, company forms (SARL, EURL, SPA) and CNRC registration.